药物信息为CAMPRAL (acamprosate calcium) Delayed-Release Tablets (FOREST PHARMACEUTICALS, Inc. ): DESCRIPTION
- DESCRIPTION
- CLINICAL STUDIES
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- PRECAUTIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to CAMPRAL (acamprosate calcium) Delayed-Release Tablets (FOREST PHARMACEUTICALS, Inc. )
- 外部链接相关的CAMPRAL (acamprosate calcium) Delayed-Release Tablets (FOREST PHARMACEUTICALS, Inc. )
CAMPRAL®(acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analogue of the amino acid neurotransmitter γ-aminobutyric acid and the amino acid neuromodulator taurine. Its chemical name is calcium acetylaminopropane sulfonate. Its chemical formula is C10H20N2O8S2Ca and molecular weight is 400.48. Its structural formula is:

Acamprosate calcium is a white, odorless or nearly odorless powder. It is freely soluble in water, and practically insoluble in absolute ethanol and dichloromethane.
Each CAMPRAL® tablet contains acamprosate calcium 333 mg, equivalent to 300 mg of acamprosate. Inactive ingredients in CAMPRAL® tablets include: crospovidone, microcrystalline cellulose, magnesium silicate, sodium starch glycolate, colloidal anhydrous silica, magnesium stearate, talc, propylene glycol and Eudragit® L 30 D or equivalent. Sulfites were used in the synthesis of the drug substance and traces of residual sulfites may be present in the drug product.
- Drug Information Provided by National Library of Medicine (NLM).
